Functional mode of action of ASP5736, a selective 5-HT5A receptor antagonist for treatment of cognitive dysfunction in schizophrenia

Authors :: Masako Furutani
Ai Moriyama
Torgny H. Svensson
Mayuko Okabe
Katsuya Harada
Noriyuki Yamamoto
Monica M. Marcus
Junko Yarimizu
Mayako Yamazaki
Source :: European Neuropsychopharmacology. 29:S414-S415
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pharmacology
business.industry
Schizophrenia (object-oriented programming)
Antagonist
Cognition
Psychiatry and Mental health
Neurology
Medicine
Pharmacology (medical)
5-HT5A receptor
Neurology (clinical)
business
Mode of action
Neuroscience
Biological Psychiatry

Full Text Access

Tools